— Know what they know.
Not Investment Advice

0RAR.L

Stratec SE
1W: -0.4% 1M: -5.5% 3M: -10.1% YTD: -5.4% 1Y: -38.2% 3Y: -75.4% 5Y: -81.1%
€17.92 ($20.72)
-1.18 (-6.18%)
 
LSE · Healthcare · Medical - Equipment & Services · €232.2M
Smart Money Score
No convergence signal
Key Statistics
Market Cap€232.2M ($268.5M)
52W Range19.1-70.2
Volume10
Avg Volume2,726
Beta0.72
Dividend€0.60
Analyst Ratings
No analyst coverage
Company Info
CEOMarcus Wolfinger
Employees1,462
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date2015-09-10
Gewerbestrasse 37
Birkenfeld 75217
DE
49 7082 7916 0
About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms